Engineered Models and Mechanisms in Cancer (EM2C)

The EM2C Group meets the 2nd Wednesday of each month from 5:30 to 6:30 pm in LSL 320E Room located on Campus at UMass Amherst. 

2019 Date



January 9th, 2019 Sallie Schneider Organoids
February 13th, 2019 Cancelled  
March 13th, 2019 Cancelled  
April 10th, 2019 Cancelled  
May 8th, 2109 Rick Arenas Melanoma and Immuno-oncology
June 12th, 2019 Cancelled  
July 10th, 2019 Cancelled  
August 14th, 2019 Cancelled  
September 11th, 2019 Sallie Schneider Development of Organoids and Organoid Analysis for IALS Grant Proposals
October 9th, 2019    
November 13th, 2019    
December 11th, 2019    

For more information on the EM2C Group please visit

2017 Date

Past Presenter


February 8th, 2017 Sallie Schneider  
April 12th, 2017 Shelly Payton  
May 10th, 2107 Neil Forbes Targeted Therapies
September 13th, 2017 Leonid Pobezinsky T-Cell Development and the Implications It Has for Cancer Immunology and Therapeutics
October 11th, 2017 Bertrand Janne d’Othee  
November 8th, 2017 Ashish A. Kulkarni Nanoscale Approaches for Therapeutic Immune Modulation


2018 Date

Past Presenter Title
April 11th, 2018
Jungwoo Lee
General Approach to Creating Bone Marrow Tissue Models for Studying Metastasis
May 9th, 2018
Yubing Sun
Biomechanical microenvironment regulates fusogenicity of breast cancer cells
September 12th, 2018
Mike Lee and Shelly Peyton
Tissue-specific drug responses of metastatic breast cancer cells
October 10th, 2018
Joe Jerry
Tumor Models
November 14th, 2018
Joe Jerry
Discussion of Models and Resources to Catalyze Cancer Research